Support for a polypill approach Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. The gene discussed is ACE; the disease is myocardial infarction.